Bestron 0.45/20 mg is a combination tablet containing Conjugated Estrogens (0.45 mg) and Bazedoxifene (20 mg), manufactured by Incepta Pharmaceuticals Ltd. in Bangladesh. This medication is primarily indicated for:
Moderate to severe vasomotor symptoms associated with menopause (e.g., hot flashes).
Prevention of postmenopausal osteoporosis in women who are at risk.